phase readout
saveNCT06714461: A Study of the Effectiveness of Additional Risk Minimization Measures Related to ARAVA® (Leflunomide) in Saudi Arabia
ACTIVE_NOT_RECRUITINGupdated 2mo ago
community read0 votes
Sponsor: Sanofi. Phase: . Conditions: Rheumatoid Arthritis, Psoriatic Arthritis
view source ↗
comments(0)
5-min edit window · permanent after that